NFSG
BBH icon

Newbridge Financial Services Group’s VanEck Biotech ETF BBH Stock Holding History

Newbridge Financial Services Group’s Portfolio BBH Stock Details BBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-100
Closed -$20K – 1416
2021
Q3 		$20K Buy
+100
New +$21K 0.01% 659

Other funds holding BBH

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
MJRIC
Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $26.4B AUM 21.05% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Newbridge Financial Services Group's BBH Position: Q4 2021 in Review

Newbridge Financial Services Group sold out of VanEck Biotech ETF (BBH) in Q4 2021, closing a stake of 100 shares — an estimated $20K sold.

Newbridge Financial Services Group first reported a position in BBH in Q3 2021 and held it in 1 quarter. The position peaked at $20K in Q3 2021. 126 funds tracked by Wall St. Rank hold BBH as of Q4 2021.

  • Newbridge Financial Services Group reported no remaining VanEck Biotech ETF position as of Q4 2021 after selling out during the quarter.
  • Newbridge Financial Services Group sold 100 VanEck Biotech ETF shares in Q4 2021, an estimated $20K.
  • Newbridge Financial Services Group first reported a position in VanEck Biotech ETF in Q3 2021 and held it in 1 quarter.
  • Newbridge Financial Services Group's VanEck Biotech ETF position peaked at $20K in Q3 2021.
  • 126 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q4 2021.

Based on Newbridge Financial Services Group's 13F filing for Q4 2021, filed 19 Jan 2022.